F&A – Where the Action Is
The foot and ankle market segment is now, for the first time, considered one of the most lucrative orthopedic segments.
$2-$5 billion, annually
Current estimates put the U.S and worldwide foot and ankle market shares north of $2 billion, and $5 billion, respectively. Annual growth rates are equally as impressive, ranging from 6% to 10%, according to the "Foot And Ankle Devices Global Market Report 2022."
Consolidation will continue
Stryker's acquisition of Wright Medical started the trend. Envois, DePuy Synthes, ConMed, Medartis, and Acumed all followed suit with acquisitions of their own, further setting the stage.
Competition is good
Among the trends playing significant roles in the growth are:
Patient-specific implants/guides
Intraoperative guidance systems
Renewed interest in minimally invasive surgery
New bioabsorbable implants that may supplant traditional fixation
Novel closure innovations
Contentious competition is all but certain.
Recent Posts
See AllDavid (niche bunion company Treace Medical Concepts ) takes on Goliath ( Stryker Corporation ) with a newly announced lawsuit , alleging...
Exactech, founded by orthopedic surgeon Dr. Bill Petty in 1985, evolved into a big player in the orthopedic space, achieving revenues of...
by Vince Vacketta, DPM Medical malpractice litigation is an unfortunate aspect of any physician’s or surgeon's practice. Orthopedic...
Comentários